BUSINESS
Dr Reddy's Chinese gamble -- build biz on early mover advantage, recent tender wins
Dr Reddy’s is the first Indian company and the second international drug company after Sandoz to be selected and win a supply tender in China under the Quality Consistency Evaluation (QCE) system.
BUSINESS
How Cipla's Umang Vohra is trying to invigorate the 84 year old company
Vohra’s first two years were spent on cutting the flab, restructuringthe business, rationalising the workforce and improving its productivity.
BUSINESS
How Wellthy Therapeutics is redefining healthcare delivery with a digital pill
The app acts as a digital personal health coach that uses technology tools machine learning and artificial intelligence to nudge the person to adopt behavioral change.
BUSINESS
Will Cequa turn the tide for Sun Pharma in US?
Sun Pharma has invested around $1 billion in the specialty business in US.
BUSINESS
Cipla looks beyond pills, keen to invest in innovations in patient care, drug delivery technologies
The company said it is interested in companies that solve unmet need in patient care, new drug delivery systems and medical records.
BUSINESS
In Singh brothers’ case, Delhi police will have to find where all the money has flown
Investigating agencies have a task at hand to find out the money trail -- where it had flown and who were the end beneficiaries
BUSINESS
Lupin plans to file Etanercept, Pegfilgrastim biosimilars in US by Q4FY20
In Europe, the second largest market for the Etanercept, Lupin is expecting approval in March 2020, and plans to commercialise it by Q1FY21.
BUSINESS
Nobel Prize: How 2019's winners are revolutionising medicine
The 2019 Nobel Prize in Physiology or Medicine has been awarded jointly to three physician-scientists for their discoveries of how cells sense and adapt to oxygen availability.
BUSINESS
Shivinder, Malvinder Singh arrest: SEBI report lays bare sordid tale of siphoning at Religare
SEBI in a March order directed Religare Enterprises and its subsidiary to recover funds to the tune of Rs 2,315.09 crore that had been diverted to various entities for the ultimate benefit of erstwhile promoters of REL
BUSINESS
Indian pharma market sees growth of 11.5% in Q2FY20
The July-October period saw outbreaks of infectious diseases in many parts of the country, aiding the growth of anti-infective segment to 14 percent YoY in the second quarter, beating overall IPM growth.
BUSINESS
Delhi-based startup Agatsa reshaping cardiac care with low cost portable ECG devices
The device costs just Rs 4,000 after discounts on popular e-commerce platforms. The low cost of the device and negligible operating costs will enable clinics to offer ECG for free as a point-of-care (PoC) diagnostic test.
BUSINESS
Pharma wrap: No respite for Glenmark, USFDA’s warning letter on Baddi facility adds to woes
The warning letter comes at a time when the company has been struggling with high debt and lack of meaningful approvals for products that can shore-up declining US sales
BUSINESS
Miracle aging treatment Botox set to face fight from this little-known Indian firm
BSE-listed Gulfic Biosciences has received approvals to manufacture and sell Botulinum toxin, better known by popular brand name Botox.
BUSINESS
Why Biocon's 10 cents insulin offer could be a game changer in fighting diabetes
Currently, blended median patient prices in LMICs are $9 per 10 ml vial translating to 36 US cents per day
BUSINESS
Apollo Hospitals to focus on cutting debt, improving operational performance
"We are bringing down the debt from Rs 3300 crore to Rs 2500 crore by the end of the financial year," said Suneeta Reddy, Managing Director of Apollo Hospitals to Moneycontrol.
BUSINESS
GSK suspends Ranitidine distribution in India, regulators seek drug testing data from pharma cos
Sources within pharma industry told Moneycontrol that Dr Reddy’s and Saraca Laboratories are two big suppliers of the Ranitidine active pharmaceutical ingredient (API) globally, from which most other companies source the API to formulate the drug.
BUSINESS
A look at how InnAccel is trying to save patients from Ventilator Acquired Pneumonia
Coeo Labs, a division of InnAccel, has developed an indigenous device called VAPCare, which automates the manual process of secretion clearance and oral cleansing performed by nurses.
BUSINESS
SEBI imposes penalties of Rs 22.7 crore on Aurobindo Pharma, promoters on insider trading charges
SEBI asked the Aurobindo and its promoters to pay the penalty within 45 days of the receipt of the order.
BUSINESS
Siemens Healthineers to make India its manufacturing hub
The company, which has invested Rs 2,500 crore in its research and development (R&D) centre in Bengaluru, has also opened a new manufacturing plant with a capex of Rs 20 crore.
BUSINESS
Weekly wrap: Philippines polio outbreak; why India can't afford to be complacent
The polio outbreak in the Philippines is confirmed to be from a circulating vaccine-derived poliovirus type 2.
BUSINESS
Make in India? Indian companies sit on Japanese encephalitis vaccine capacities for years, as govt imports Chinese vaccine
“The Chinese company which built huge capacities has been dumping the vaccine 20-30 cents to a dollar in India per dose, we couldn’t compete at that price,” said a top executive from one of the vaccine company mentioned in the story.
BUSINESS
Strides re-enters injectable biz, to take controlling stake in Stelis Biopharma
The Strides board on September 20 approved an additional investment up to $40 million in Stelis, over a period of 24 months for the purpose.
BUSINESS
Slowdown blues: Mega summits to woo investments take a hit as investors get cold feet
The government had to cancel two such mega events recently.
BUSINESS
E-cigarettes banned: What led government to terminate ENDS?
The ordinance proposes maximum imprisonment of up to one year along with a fine of Rs 1 lakh for first-time violators, and imprisonment of upto 3 yrs & fine upto Rs 5 lakh for subsequent offences.
